In addition, Shi et al. considered CDK1 and MAD2L1 crucial for the progression of lung cancer, since patients with increased CDK1 or MAD2L1 expression had a high risk of recurrence and poor prognosis [60]. Here, MAD2L1 is linked to lung carcinoma.